Stay updated on Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial

Sign up to get notified when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-03T23:43:56.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page, and the footer revision advances to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:40:55.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:05.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, replacing detailed study content with a generic error page. This indicates that access to the trial information is blocked on this URL.
    Difference
    18%
    Check dated 2026-09-23T00:49:09.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.6.6 to v3.7.0, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-09-16T00:07:21.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page footer's revision label changed from v3.6.5 to v3.6.6, indicating a new build. The update does not modify the trial information or other visible content.
    Difference
    0.1%
    Check dated 2026-09-01T21:00:24.000Z thumbnail image

Stay in the know with updates to Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.